Effects of molecular weight and degree of acetylation on the release of nitric oxide from chitosan-nitric oxide adducts

Biofertilizers and nanofertilizers for sustainable agriculture: Phycoprospects and challenges

Increased food demands and ceasing nutrient deposits have resulted in a great shortfall between the food supply and demand and would be worse in the years to come. Higher inputs of synthetic fertilizers on lands have resulted in environmental pollution, persistent changes in the soil ecology, and physicochemical conditions. This has greatly decreased the natural soil fertility thereby hindering agricultural productivity, human health, and hygiene. Bio-based resilient nutrient sources as wastewater-derived algae are promising as a complete nutrient for agriculture and have the potential to be used in soilless cultivations. Innovations in nano-fortification and nano-sizing of minerals and algae have the potential to facilitate nutrients bioavailability and efficacy for a multifold increase in productivity. In this context, various options on minerals nanofertilizer application in agricultural food production besides efficient biofertilizer have been investigated. Algal biofertilizer with the nanoscale application has huge prospects for further agriculture productivities and fosters suitable development.

Therapeutic Delivery of Nitric Oxide Utilizing Saccharide-Based Materials

As a gasotransmitter, nitric oxide (NO) regulates physiological pathways and demonstrates therapeutic effects such as vascular relaxation, anti-inflammation, antiplatelet, antithrombosis, antibacterial, and antiviral properties. However, gaseous NO has high reactivity and a short half-life, so NO delivery and storage are critical questions to be solved. One way is to develop stable NO donors and the other way is to enhance the delivery and storage of NO donors from biomaterials. Most of the researchers studying NO delivery and applications are using synthetic polymeric materials, and they have demonstrated significant therapeutic effects of these NO-releasing polymeric materials on cardiovascular diseases, respiratory disease, bacterial infections, etc. However, some researchers are exploring saccharide-based materials to fulfill the same tasks as their synthetic counterparts while avoiding the concerns of biocompatibility, biodegradability, and sustainability. Saccharide-based materials are abundant in nature and are biocompatible and biodegradable, with wide applications in bioengineering, drug delivery, and therapeutic disease treatments. Saccharide-based materials have been implemented with various NO donors (like S-nitrosothiols and N-diazeniumdiolates) via both chemical and physical methods to deliver NO. These NO-releasing saccharide-based materials have exhibited controlled and sustained NO release and demonstrated biomedical applications in various diseases (respiratory, Crohn's, cardiovascular, etc.), skin or wound applications, antimicrobial treatment, bone regeneration, anticoagulation, as well as agricultural and food packaging. This review aims to highlight the studies in methods and progress in developing saccharide-based NO-releasing materials and investigating their potential applications in biomedical, bioengineering, and disease treatment.

Nitric Oxide-Releasing Macromolecular Scaffolds for Antibacterial Applications

Exogenous nitric oxide (NO) represents an attractive antibacterial agent because of its ability to both disperse and directly kill bacterial biofilms while avoiding resistance. Due to the challenges associated with administering gaseous NO, NO-releasing macromolecular scaffolds are developed to facilitate NO delivery. This progress report describes the rational design and application of NO-releasing macromolecular scaffolds as antibacterial therapeutics. Special consideration is given to the role of the physicochemical properties of the NO storage vehicles on antibacterial or anti-biofilm activity.

S-Nitrosothiol-modified nitric oxide-releasing chitosan oligosaccharides as antibacterial agents

S-Nitrosothiol-modified chitosan oligosaccharides were synthesized by reaction with 2-iminothiolane hydrochloride and 3-acetamido-4,4-dimethylthietan-2-one, followed by thiol nitrosation. The resulting nitric oxide (NO)-releasing chitosan oligosaccharides stored ∼0.3μmol NO mg(-1) chitosan. Both the chemical structure of the nitrosothiol (i.e. primary and tertiary) and the use of ascorbic acid as a trigger for NO donor decomposition were used to control the NO-release kinetics. With ascorbic acid, the S-nitrosothiol-modified chitosan oligosaccharides elicited a 4-log reduction in Pseudomonas aeruginosa viability. Confocal microscopy indicated that the primary S-nitrosothiol-modified chitosan oligosaccharides associated more with the bacteria relative to the tertiary S-nitrosothiol system. The primary S-nitrosothiol-modified chitosan oligosaccharides elicited minimal toxicity towards L929 mouse fibroblast cells at the concentration necessary for a 4-log reduction in bacterial viability, further demonstrating the potential of S-nitrosothiol-modified chitosan oligosaccharides as NO-release therapeutics.

Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents

Secondary amine-functionalized chitosan oligosaccharides of different molecular weights (i.e., ~2500, 5000, 10,000) were synthesized by grafting 2-methyl aziridine from the primary amines on chitosan oligosaccharides, followed by reaction with nitric oxide (NO) gas under basic conditions to yield N-diazeniumdiolate NO donors. The total NO storage, maximum NO flux, and half-life of the resulting NO-releasing chitosan oligosaccharides were controlled by the molar ratio of 2-methyl aziridine to primary amines (e.g., 1:1, 2:1) and the functional group surrounding the N-diazeniumdiolates (e.g., polyethylene glycol (PEG) chains), respectively. The secondary amine-modified chitosan oligosaccharides greatly increased the NO payload over existing biodegradable macromolecular NO donors. In addition, the water-solubility of the chitosan oligosaccharides enabled their penetration across the extracellular polysaccharides matrix of Pseudomonas aeruginosa biofilms and association with embedded bacteria. The effectiveness of these chitosan oligosaccharides at biofilm eradication was shown to depend on both the molecular weight and ionic characteristics. Low molecular weight and cationic chitosan oligosaccharides exhibited rapid association with bacteria throughout the entire biofilm, leading to enhanced biofilm killing. At concentrations resulting in 5-log killing of bacteria in Pseudomonas aeruginosa (P. aeruginosa) biofilms, the NO-releasing and control chitosan oligosaccharides elicited no significant cytotoxicity to mouse fibroblast L929 cells in vitro.

Novel quantum dots-carboxymethyl chitosan nanocomposite nitric oxide donors capable of detecting release of nitric oxide in situ

Nitric oxide (NO) donor compounds are primarily monofunctional in that they release NO under the requisite conditions. To detect the amount and duration of NO released, subsequent analysis methods are required. It would be advantageous if a NO donor compound could both release and detect NO at the same time. This would eliminate potential errors in the analysis. In this paper, novel cadmium telluride quantum dots (CdTe QD)-carboxymethyl chitosan (CMCS) nanocomposite NO donors, including both diazeniumdiolates and fluorescence probes, were fabricated by first synthesizing CdTe QD in CMCS aqueous solution and then reacting NO as well as ethyl bromide with the resultant CdTe QD-CMCS nanocomposites. Transmission electron microscopy, scanning electron microscopy and particle size analysis were used to examine the morphology and size distribution of the CdTe QD-CMCS nanocomposite NO donors. The donors are nanospheres with CdTe QD encapsulated and have dimensions of ~300 nm. Fourier transform infrared spectroscopy, X-ray diffraction, X-ray photoelectron spectroscopy and contact angle tests were employed to characterize the chemical structure of the donors, and the results also show that CdTe QD are well incorporated into CMCS, and many of them are close to the surface of the donors. The precursors of the donors exhibit a fluorescent effect, and the fluorescence can be quenched by NO. The donors can release NO spontaneously in a phosphate-buffered saline solution similar to a physiological environment, and can quantitatively detect the release of NO in situ based on fluorescence quenching of the donors by the NO.